AltruBio – Talk Bio

Actionable Insights Powered by AI

AltruBio Secures $225 Million for Phase II Trials of Novel Immune Checkpoint Enhancing Antibody

11 months ago talkbio0Tagged AltruBio, Antibodies, Biotechnology, Cancer Therapeutic Procedure, healthcare innovation, Immune, Immunotherapy, Phase 2 Clinical Trials

AltruBio, funding, Phase II trials, immune checkpoint enhancing antibody, cancer treatment, immunotherapy, biotechnology, healthcare innovation.

AltruBio Secures $225M for Midphase Ulcerative Colitis Program Following Checkpoint Drug Modification

11 months ago talkbio0Tagged AltruBio, Biotechnology, checkpoint drug, Drug Development, healthcare innovation, midphase, midphase program, Ulcerative Colitis

AltruBio, checkpoint drug, ulcerative colitis, $225M funding, midphase program, biotechnology, drug development, healthcare innovation.